Research identifies a way to make cancer cells more responsive to chemotherapy
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Cancer
3 hours ago |
5 / 5 (2) |
0
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
Arthritis & Rheumatism
May 22, 2013 |
5 / 5 (2) |
0
|
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
Cancer
May 21, 2013 |
not rated yet |
0
Gene associated with adolescent idiopathic scoliosis identified
Researchers from the RIKEN Center for Integrative Medical Sciences in Japan have identified the first gene to be associated with adolescent idiopathic scoliosis (also called AIS) across Asian and Caucasian ...
Genetics
May 12, 2013 |
5 / 5 (1) |
0
|
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
(Medical Xpress)—Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers ...
Cancer
May 10, 2013 |
5 / 5 (1) |
0
|
Asthma drug found highly effective in treating chronic, severe hives and itch
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. ...
Immunology
Feb 24, 2013 |
5 / 5 (2) |
0
|
FDA approves Procysbi for nephropathic cystinosis
(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. ...
Medications
May 02, 2013 |
not rated yet |
0
Modified formula aims to prevent death in premature infants
Necrotizing Entercolitis, an infection and inflammation that causes destruction of the intestine,affects about 10,000 babies a year in the country, and mortality rates are roughly 40 percent.
Medical research
May 10, 2013 |
not rated yet |
0
Cell therapy using patient's own bone marrow may present option for heart disease
Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the ...
Cardiology
Mar 24, 2012 |
5 / 5 (5) |
0
|
New discovery could lead to new way to screen drugs for adverse reactions
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy ...
Immunology
May 29, 2012 |
5 / 5 (3) |
0
|
Gene clue to drug resistance in African sleeping sickness
(Medical Xpress) -- Researchers have identified a gene that controls susceptibility to drug treatment in Trypanosoma brucei, the parasite responsible for African sleeping sickness.
Diseases, Conditions, Syndromes
Jun 19, 2012 |
3 / 5 (2) |
0
|
New gene study of ADHD points to defects in brain signaling pathways
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility ...
Attention deficit disorders
Dec 04, 2011 |
4 / 5 (5) |
3
|
Gene therapy holds promise for reversing congenital hearing loss
A new gene therapy approach can reverse hearing loss caused by a genetic defect in a mouse model of congenital deafness, according to a preclinical study published by Cell Press in the July 26 issue of the journal Neuron. The fi ...
Neuroscience
Jul 25, 2012 |
4 / 5 (3) |
0
|
Cancer studies often lack necessary rigor to answer key questions
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Cancer
Apr 29, 2013 |
5 / 5 (1) |
0
Mathematical models out-perform doctors in predicting cancer patients' responses to treatment
Mathematical prediction models are better than doctors at predicting the outcomes and responses of lung cancer patients to treatment, according to new research presented today (Saturday) at the 2nd Forum of the European Society ...
Cancer
Apr 20, 2013 |
4 / 5 (1) |
0
|
